Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H11N3O2 |
InChIKeyKOUGHMOSYJCJLE-UHFFFAOYSA-N |
CAS Registry188106-83-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - | |
Neoplasms | Preclinical | GB | - |